The European Circular Bioeconomy Fund (ECBF) expands Aphea.Bio Series B funding round to EUR 18 million
Aphea.Bio uniquely taps into the natural biodiversity of microorganisms to identify and develop novel biostimulant and biocontrol products.
Aphea.Bio uniquely taps into the natural biodiversity of microorganisms to identify and develop novel biostimulant and biocontrol products.
The initial focus is to develop high yielding, high-protein soybean varieties.
Making plants more resilient through genome duplication
Soy: a miracle bean?